CClinicalTrials.gg
RecruitingNCT06887244Updated Mar 26, 2025

Effectiveness of Nurse Tele-consultation on the Quality of Elective Colonoscopy, Procedure-related Anxiety, and Financial Toxicity

An interventional study of Tele-consultation in Patient Satisfaction and Efficacy of Bowel-preparation and Colon Cancer Prevention, sponsored by National Cancer Institute, Naples. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-03-26.

Sponsored by National Cancer Institute, Naples · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Registered 8 months after the study started (first participant enrolled Jun 2024, registered Mar 2025).
  • Started Jun 2024; still recruiting 2 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
534
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This is a multicenter, non-pharmacological, experimental, prospective, randomized study, with two arms (1:1) in a single-blind design. The study aims to evaluate the effectiveness of a tele-consultation procedure in patients undergoing elective colonoscopy in terms of quality of the exam, anxiety procedure-related and financial toxicity.

Read the detailed description

The aim of this study is to evaluate the effectiveness, in daily clinical practice, of a tele-consultation procedure (defined as a telephone consultation with the patient conducted by nursing staff with an appropriate level of experience in digestive endoscopy) with the goal of:

  1. improving adherence to methods and timing for the correct intake of the intestinal preparation by patients undergoing elective colonoscopy;
  2. assessing whether the tele-consultation can reduce anxiety and procedure-related stress, promoting a better emotional state in patients undergoing colonoscopy.
02

Conditions studied

  • Patient Satisfaction and Efficacy of Bowel-preparation
  • Colon Cancer Prevention

Keywords

  • colonoscopy
  • tele-consultation procedure
  • colon cancer
  • financial toxicity
  • anxiety procedure-related
03

In context

Colonic Neoplasms

1,432 studies on the registry are indexed under Colonic Neoplasms; 357 are open to participants now.

This study's planned enrollment of 534 is above the median of 90 across 1,034 interventional studies indexed under Colonic Neoplasms.

Browse Colonic Neoplasms studies →

Lead sponsor

National Cancer Institute, Naples is the lead sponsor of 112 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Subjects eligible for outpatient pancolonoscopy:

  • for diagnostic purposes;
  • for screening purposes;
  • for post-polypectomy follow-up;
  • of both genders;
  • of all ethnicities;

Exclusion criteria

Exclusion Criteria:

  • Patients under 18 years of age or over 80 years of age;
  • Patients on waiting lists with SHORT priority: the procedure to be provided within a short time (no more than 10 days);
  • Patients included in GOM pathways who undergo colonoscopy within 10 days;
  • Pregnancy;
  • Presence of known contraindications to bowel preparation;
  • Presence of known contraindications to performing pancolonoscopy;
  • Patients who have undergone colonic resection and/or have a colostomy/ileostomy;
  • Patients with cognitive impairments;
  • Patients declared legally incompetent or unable to understand and make decisions;
  • Patients unable to provide informed consent.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
534 participants (estimated)

Study arms

  • Experimental
    nurse tele-consultation arm

    Use of the nurse tele-consultation tool in the Intervention arm administered 5±2 days before the colonoscopy procedure.

    Other: Tele-consultation

  • No intervention
    Standard arm

Interventions

  • OtherTele-consultation

    Tele-consultation procedure is defined as a telephone consultation with the patient conducted by nursing staff with an appropriate level of experience in digestive endoscopy

06

What researchers measure

Primary outcomes

  1. Evaluation of intestinal preparation. BBPS score (BOSTON BOWEL PREPARATION SCORE)

    Compare the quality of the colonoscopy between patients who received tele-consultation (INTERVENTION Group) and those who did not receive tele-consultation (CONTROL Group) based on the BBPS score (BOSTON BOWEL PREPARATION SCORE). The BBPS score ranges from 0 to 9 based on intestinal preaparation in cecum, colon and rectum. Each section is scored on a scale of 0 to 3 (0= unprepared to 3= excellent). The total BBPS score is the sum of the scores from the three sections (score 0 to 5=Poor preparation; score 6 to 7= fair preparation; score 8 to 9=good preparation). A higher score indicates better bowel preparation, which is ideal for a successful colonoscopy.

    Time frame: at the end of colonoscopy up to 12 months

  2. H.A.D.S. (Hospital Anxiety and Depression Scale)

    Compare the quality of the emotional state between the sample of patients who received tele-consultation (INTERVENTION Group) and those who did not receive tele-consultation (CONTROL Group) based on the H.A.D.S. score (Hospital Anxiety and Depression Scale).The scale consists of 14 items, with 7 questions related to anxiety and 7 related to depression. Each item is rated on a 4-point scale (from 0=not at all to 3= most of the time). The total score for each section (anxiety and depression) can range from 0 to 21, and then the scores from both sections are combined for a total score ranging from 0 to 42. The minimun score is 0-7 that means normal (little to no anxiety or depression). The maximum score is 15-21 that means severe (significant anxiety or depression).

    Time frame: baseline, before colonoscopy up to 12 months

Secondary outcomes

  1. Financial Toxicity (FT) using the "PROFFIT questionnaire"

    Assessment of FT through PROFFIT questionnaire. This is an Italian instrument for evaluating FT in patients in the Italian healthcare context. It includes 16 total items, 7 measuring FT (defining the PROFFIT financial score) and 9 measuring possible determinants of FT. The score range from 0-100 (the higher value means precence of FT).

    Time frame: baseline (before colonoscopy) up to 12 months

  2. Effectiveness of a colonoscopy in detecting adenomas. Adenoma Detection Rate (ADR)

    Quality of colonoscopies between patients who received tele-consultation and those who did not receive tele-consultation based on ADR. ADR represents the percentage of patients undergoing colonoscopy in which at least one adenoma is detected.

    Time frame: at the end of colonoscopy up to 12 months

  3. Rate of cecal intubation

    Cecal intubation rate in patients of the 2 study groups

    Time frame: at the end of colonoscopy up to 12 months

07

Study locations

1 of 1 sites recruiting
  • S.S.D. Garoenterologia ed Endoscopia Digestiva
    Naples, 80131, Italy
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06887244
Lead sponsor
National Cancer Institute, Naples
Responsible party
Sponsor
First posted
Mar 20, 2025
Start date
Jun 24, 2024
Primary completion
May 31, 2025 (estimated)
Completion
May 31, 2026 (estimated)
Last update
Mar 26, 2025

Study contacts

Francesco De Falco, Nursing degree
Contact
endoscopia@istitutotumori.na.it
0811770813 ext. 0039
Francesco De Falco, Nursing degree
principal investigator · National Cancer Institute, IRCCS Fondazione G. Pascale

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion